Plassche Douglas's Form 4 filing
Elite Pharmaceuticals Inc (ELTP) · filed Oct 28, 2024
- Accession no.
- 0001493152-24-042726
- Filed
- Oct 28, 2024, 5:23 PM ET
- Trade date
- Oct 23-24, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $562.3K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Plassche DouglasCIK 0001600946 | Officer (SVP of Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2024 | Common Stock | SSaleDisposed | −800,000 | $0.49 | −$392,000 | 333,932 | Direct | |
| Oct 24, 2024 | Common Stock | SSaleDisposed | −333,932 | $0.51 | −$170,305.32 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.